Correlation Between Tenax Therapeutics and Monopar Therapeutics
Can any of the company-specific risk be diversified away by investing in both Tenax Therapeutics and Monopar Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tenax Therapeutics and Monopar Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tenax Therapeutics and Monopar Therapeutics, you can compare the effects of market volatilities on Tenax Therapeutics and Monopar Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tenax Therapeutics with a short position of Monopar Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tenax Therapeutics and Monopar Therapeutics.
Diversification Opportunities for Tenax Therapeutics and Monopar Therapeutics
0.84 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Tenax and Monopar is 0.84. Overlapping area represents the amount of risk that can be diversified away by holding Tenax Therapeutics and Monopar Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Monopar Therapeutics and Tenax Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tenax Therapeutics are associated (or correlated) with Monopar Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Monopar Therapeutics has no effect on the direction of Tenax Therapeutics i.e., Tenax Therapeutics and Monopar Therapeutics go up and down completely randomly.
Pair Corralation between Tenax Therapeutics and Monopar Therapeutics
Given the investment horizon of 90 days Tenax Therapeutics is expected to generate 1.74 times less return on investment than Monopar Therapeutics. But when comparing it to its historical volatility, Tenax Therapeutics is 1.97 times less risky than Monopar Therapeutics. It trades about 0.1 of its potential returns per unit of risk. Monopar Therapeutics is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest 1,783 in Monopar Therapeutics on August 28, 2024 and sell it today you would earn a total of 157.00 from holding Monopar Therapeutics or generate 8.81% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Tenax Therapeutics vs. Monopar Therapeutics
Performance |
| Timeline |
| Tenax Therapeutics |
| Monopar Therapeutics |
Tenax Therapeutics and Monopar Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Tenax Therapeutics and Monopar Therapeutics
The main advantage of trading using opposite Tenax Therapeutics and Monopar Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tenax Therapeutics position performs unexpectedly, Monopar Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Monopar Therapeutics will offset losses from the drop in Monopar Therapeutics' long position.| Tenax Therapeutics vs. Allarity Therapeutics | Tenax Therapeutics vs. Neurobo Pharmaceuticals | Tenax Therapeutics vs. Virax Biolabs Group | Tenax Therapeutics vs. Quoin Pharmaceuticals Ltd |
| Monopar Therapeutics vs. Eliem Therapeutics | Monopar Therapeutics vs. Scpharmaceuticals | Monopar Therapeutics vs. Milestone Pharmaceuticals | Monopar Therapeutics vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Complementary Tools
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |